ArticleThe Lancet. Respiratory medicine2020
Physiological and biological heterogeneity in COVID-19-associated acute respiratory distress syndrome.
Article in The Lancet. Respiratory medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed.
- Role of ACE1, ACE2, and CCR5-Δ32 Polymorphisms in the Transmission of SARS-CoV-2 to Intimate Contacts.Biology · 2025Article
- Neurological manifestations of SARS-CoV-2: complexity, mechanism and associated disorders.European journal of medical research · 2023Review
- Personalized medicine using omics approaches in acute respiratory distress syndrome to identify biological phenotypes.Respiratory research · 2022Review
- Resistin and IL-15 as Predictors of Invasive Mechanical Ventilation in COVID-19 Pneumonia Irrespective of the Presence of Obesity and Metabolic Syndrome.Journal of personalized medicine · 2022Article
- Effect of tocilizumab on intensive care patients with Covid-19 pneumonia, a retrospective cohort study.Turkish journal of medical sciences · 2022Article
- Thrombosis and fibrosis: mutually inclusive targets to combat in COVID-19.Future science OA · 2022Article
- Biomarkers of sequela in adult patients convalescing from COVID-19.Advances in biomarker sciences and technology · 2022Article
- Whole patient knowledge modeling of COVID-19 symptomatology reveals common molecular mechanisms.Frontiers in molecular medicine · 2022Article
- Signaling Through FcγRIIA and the C5a-C5aR Pathway Mediate Platelet Hyperactivation in COVID-19.Frontiers in immunology · 2022Article
- The Renin-Angiotensin-Aldosterone System in COVID-19-related and Non-COVID-19-related Acute Respiratory Distress Syndrome: Not So Different after All?American journal of respiratory and critical care medicine · 2021Article
- Liposomal remdesivir inhalation solution for targeted lung delivery as a novel therapeutic approach for COVID-19.Asian journal of pharmaceutical sciences · 2021Article
- Structural and molecular perspectives of SARS-CoV-2.Methods (San Diego, Calif.) · 2021Review
- Ultramicronized Palmitoylethanolamide in the Management of Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation.International journal of molecular sciences · 2021Article
- Longitudinal urinary biomarkers of immunological activation in covid-19 patients without clinically apparent kidney disease versus acute and chronic failure.Scientific reports · 2021Article
- COVID-19-Associated Acute Respiratory Distress Syndrome: Lessons from Tissues and Cells.Critical care clinics · 2021Review
- Carotenoids: Therapeutic Strategy in the Battle against Viral Emerging Diseases, COVID-19: An Overview.Preventive nutrition and food science · 2021Review
- Multi-dimensional and longitudinal systems profiling reveals predictive pattern of severe COVID-19.iScience · 2021Article
- Systemic and organ-specific immune-related manifestations of COVID-19.Nature reviews. Rheumatology · 2021Review
- Signaling through FcγRIIA and the C5a-C5aR pathway mediates platelet hyperactivation in COVID-19.bioRxiv : the preprint server for biology · 2021Article
- [CIBERESUCICOVID: A strategic project for a better understanding and clinical management of COVID-19 in critical patients].Archivos de bronconeumologia · 2021Article
Corrections and comments
- Comment on
- Comment on
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.